Bruker Statistics
Total Valuation
Bruker has a market cap or net worth of $5.75 billion. The enterprise value is $7.80 billion.
| Market Cap | 5.75B |
| Enterprise Value | 7.80B |
Important Dates
The next confirmed earnings date is Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | Mar 17, 2025 |
Share Statistics
Bruker has 151.71 million shares outstanding. The number of shares has increased by 1.56% in one year.
| Current Share Class | 151.71M |
| Shares Outstanding | 151.71M |
| Shares Change (YoY) | +1.56% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 31.93% |
| Owned by Institutions (%) | 80.83% |
| Float | 103.19M |
Valuation Ratios
The trailing PE ratio is 49.92 and the forward PE ratio is 14.41. Bruker's PEG ratio is 0.99.
| PE Ratio | 49.92 |
| Forward PE | 14.41 |
| PS Ratio | 1.68 |
| Forward PS | 1.62 |
| PB Ratio | 3.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 42.27 |
| P/OCF Ratio | 22.87 |
| PEG Ratio | 0.99 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.13, with an EV/FCF ratio of 57.35.
| EV / Earnings | 68.96 |
| EV / Sales | 2.32 |
| EV / EBITDA | 13.13 |
| EV / EBIT | 19.01 |
| EV / FCF | 57.35 |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 1.24.
| Current Ratio | 1.60 |
| Quick Ratio | 0.70 |
| Debt / Equity | 1.24 |
| Debt / EBITDA | 3.45 |
| Debt / FCF | 16.51 |
| Interest Coverage | 8.57 |
Financial Efficiency
Return on equity (ROE) is 7.05% and return on invested capital (ROIC) is 7.48%.
| Return on Equity (ROE) | 7.05% |
| Return on Assets (ROA) | 5.10% |
| Return on Invested Capital (ROIC) | 7.48% |
| Return on Capital Employed (ROCE) | 9.07% |
| Revenue Per Employee | $295,402 |
| Profits Per Employee | $9,925 |
| Employee Count | 11,396 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.65 |
Taxes
In the past 12 months, Bruker has paid $91.40 million in taxes.
| Income Tax | 91.40M |
| Effective Tax Rate | 44.54% |
Stock Price Statistics
The stock price has decreased by -51.42% in the last 52 weeks. The beta is 1.18, so Bruker's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -51.42% |
| 50-Day Moving Average | 44.47 |
| 200-Day Moving Average | 57.02 |
| Relative Strength Index (RSI) | 42.08 |
| Average Volume (20 Days) | 2,739,833 |
Short Selling Information
The latest short interest is 8.53 million, so 5.62% of the outstanding shares have been sold short.
| Short Interest | 8.53M |
| Short Previous Month | 7.98M |
| Short % of Shares Out | 5.62% |
| Short % of Float | 8.26% |
| Short Ratio (days to cover) | 4.21 |
Income Statement
In the last 12 months, Bruker had revenue of $3.37 billion and earned $113.10 million in profits. Earnings per share was $0.76.
| Revenue | 3.37B |
| Gross Profit | 1.68B |
| Operating Income | 410.30M |
| Pretax Income | 455.90M |
| Net Income | 113.10M |
| EBITDA | 594.10M |
| EBIT | 410.30M |
| Earnings Per Share (EPS) | $0.76 |
Balance Sheet
The company has $194.10 million in cash and $2.25 billion in debt, giving a net cash position of -$2.05 billion or -$13.52 per share.
| Cash & Cash Equivalents | 194.10M |
| Total Debt | 2.25B |
| Net Cash | -2.05B |
| Net Cash Per Share | -$13.52 |
| Equity (Book Value) | 1.82B |
| Book Value Per Share | 11.74 |
| Working Capital | 771.90M |
Cash Flow
In the last 12 months, operating cash flow was $251.30 million and capital expenditures -$115.30 million, giving a free cash flow of $136.00 million.
| Operating Cash Flow | 251.30M |
| Capital Expenditures | -115.30M |
| Free Cash Flow | 136.00M |
| FCF Per Share | $0.90 |
Margins
Gross margin is 50.00%, with operating and profit margins of 12.19% and 3.36%.
| Gross Margin | 50.00% |
| Operating Margin | 12.19% |
| Pretax Margin | 6.10% |
| Profit Margin | 3.36% |
| EBITDA Margin | 17.65% |
| EBIT Margin | 12.19% |
| FCF Margin | 4.04% |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 26.35% |
| Buyback Yield | -1.56% |
| Shareholder Yield | -1.03% |
| Earnings Yield | 1.97% |
| FCF Yield | 2.37% |
Analyst Forecast
The average price target for Bruker is $63.40, which is 67.33% higher than the current price. The consensus rating is "Buy".
| Price Target | $63.40 |
| Price Target Difference | 67.33% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 5.72% |
| EPS Growth Forecast (5Y) | 42.55% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bruker has an Altman Z-Score of 3.08 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.08 |
| Piotroski F-Score | 4 |